This holiday season, millions of people will be celebrating with family and friends. Preparing and sharing food is often the centerpiece of getting together. However, while good cheer may fill the air, danger could be lurking just beyond the door to the kitchen or dining room.
A study published this week in the Journal of the American College of Cardiology (JACC) found that seven major cardiovascular societies were more likely to distribute awards to men and white individuals when compared to women and those who identify as Asian, Hispanic/Latino, and Black.
For many high school football athletes who play on teams in underserved communities, access to athletic trainers or a licensed physician is a rarity but Cedars-Sinai Kerlan-Jobe Institute Surgeon and Team HEAL (Helping Enrich Athletes' Lives) Founder, Clarence Shields Jr., MD, has been working on a prescription to even that playing field.
A new study by Cedars-Sinai investigators describes risk factors that could make it more likely for people who have chronic pancreatitis, an ongoing inflammation of the pancreas, to develop diabetes. The findings are published in Diabetes Care.
Diabetes is a chronic health condition that impacts how the body turns food into energy. More than 37 million people in the United States have Type 2 diabetes, the most common form of the metabolic disorder, according to the Centers for Disease Control and Prevention. An additional 96 million adults have prediabetes and most of them are unaware they are developing a serious chronic disease.
In a study of pregnant women in the United States, Cedars-Sinai investigators found that a specific imbalance of two placental proteins could predict which women were at risk of developing a severe form of preeclampsia, a life-threatening blood pressure disorder.
De acuerdo a un nuevo análisis dirigido por investigadores de Cedars-Sinai y llevado a cabo en tres grandes sistemas de salud, el control y manejo de la hipertensión empeoraron durante los primeros meses de la pandemia de COVID-19.
The commercials said that if you joined, you could “Live the adventure.” They were for the U.S. Navy, and Gregory Jones, 16, took note.
November is Pancreatic Cancer Awareness Month as well as National Lung Cancer Awareness Month, and experts from Cedars-Sinai Cancer are available to discuss the newest research and treatment options.
Neuroscientists from Cedars-Sinai will present—and are available to comment on—cutting-edge brain research at the sixth International Human Single Neuron Meeting Nov. 10-11 at UCLA, and Neuroscience 2022, the annual meeting of the Society for Neuroscience, Nov. 12-16 in San Diego.
Heitham T. Hassoun, MD, Vice President & Medical Director, Cedars Sinai International, is headlining a panel discussion about how healthcare professionals can improve the patient experience during the The International Hospital Federation’s upcoming World Hospital Congress.
Investigators from Cedars-Sinai Cancer have identified an investigational therapeutic approach that could be effective against treatment-resistant prostate cancer. Results of their Phase II clinical trial, published in the peer-reviewed journal Molecular Therapy, have led to a larger, multicenter trial that will soon be underway.
Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at Cedars-Sinai are presenting an array of innovative research data and leading discussions on medical breakthroughs during the American Heart Association (AHA) Scientific Sessions, taking place in Chicago, Nov. 5-7.
Hypertension control and management worsened during the early months of the COVID-19 pandemic, according to a new analysis conducted at three large health systems, led by Cedars-Sinai investigators.
A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
Once again this year, the Neonatal Intensive Care Unit (NICU) at Cedars-Sinai Guerin Children’s celebrated Halloween with special hand-sewn costumes for the medical center’s smallest babies. The costumes are designed for babies as little as 2 pounds and are based on characters in famous children’s books.
Cedars-Sinai has been awarded a five-year, $8 million grant from California’s stem cell agency to launch an innovative new clinic that will expand patients’ access to stem cell and gene therapies, increase research and training in regenerative medicine, foster greater collaboration with eight similar clinics across the state and help educate the public about stem cell and related therapies.
Ahead of World Stroke Day, Oct. 29, investigators from the Department of Neurology at Cedars-Sinai have new information on stroke-related health disparities.
Several recent discoveries show that the accuracy of diagnosing coronary artery disease and predicting patient risk is improved with the help of artificial intelligence (AI) models developed by scientists in the Division of Artificial Intelligence in Medicine at Cedars-Sinai.
A subset of healthcare workers vaccinated against COVID-19 had unexpectedly low responses to the immunizations, according to Cedars-Sinai investigators. The findings of the new study are published in iScience, a Cell Press journal.
Eugene Kim, MD, a leader in pediatric general surgery and neuroblastoma research, has been named director of the Division of Pediatric General Surgery and vice chair of Pediatric Surgery at Cedars-Sinai Guerin Children’s.
Medical oncologist Tiffany Shaw, MD, has joined Cedars-Sinai Cancer as regional medical director for Supportive Care Medicine at Huntington Cancer Center, an affiliate of Cedars-Sinai Cancer.
Cedars-Sinai and other hospitals nationwide are seeing a surge in cases of pediatric RSV (respiratory syncytial virus) that are showing up earlier than expected this year. Healthcare providers are worried about the onset of the virus combined with the additional threats of the flu and COVID-19 as we head into winter.
Linda Burnes Bolton, DrPH, RN, FAAN, Cedars-Sinai chief nursing officer emeritus, has been selected to receive the 2022 Lifetime Legacy Award from the American Academy of Nursing. The award recognizes Burnes Bolton’s longstanding leadership and contributions throughout her 50-year career to improve patient care, advance health equity and promote the nursing profession.
New data analysis from the Smidt Heart Institute at Cedars-Sinai found that deaths from heart attacks rose significantly during pandemic surges, including the COVID-19 Omicron surges, overall reversing a heart-healthier pre-pandemic trend.
The Smidt Heart Institute at Cedars-Sinai has selected leading vascular surgeon Donald Baril, MD, as director of the Vascular Surgery Fellowship Program. Baril, who joined Cedars-Sinai in 2020, aims to advance the academic medical center’s excellence in vascular care, research and education for current and future fellows.
Physician scientists from the Department of Radiation Oncology at Cedars-Sinai Cancer will present research and discuss advances in clinical care at the American Society for Radiation Oncology (ASTRO) annual meeting Oct. 23-26 in San Antonio.
Although breast cancer is more common in women, during October, Breast Cancer Awareness Month, experts from Cedars-Sinai Cancer are reminding men that they are at risk as well. One in every 100 breast cancers in the U.S. is diagnosed in a man, according to the Centers for Disease Control and Prevention.
Investigators from the departments of Neurology, Neurosurgery, Psychiatry, Medicine, and Biomedical Sciences at Cedars-Sinai have shown that an immune-suppressing drug similar to one used to treat severe COVID-19 reversed symptoms of delirium in mice whose lungs were injured during mechanical breathing assistance.
Cedars-Sinai physicians and scientists will share the results of new research aimed at improving the treatment of digestive diseases during the international meeting of the American College of Gastroenterology (ACG). The clinical conference will take place Oct. 21-26 in Charlotte, North Carolina, and is available for virtual and in-person attendance.
After 11 years spent in medical school, residency and fellowships, Elizabeth Chou, MD, a vascular surgeon who recently joined the Smidt Heart Institute at Cedars-Sinai, has earned her dream career. And she has no plans of stopping there. She’s on a path toward ensuring women in vascular surgery are represented—as incoming physicians and as patients.
Un nuevo estudio dirigido por investigadores de Cedars-Sinai encontró que el uso de pruebas de aliento para identificar perfiles de gases intestinales puede conducir a terapias más personalizadas para personas diagnosticadas con síndrome del intestino irritable (SII). El trastorno gastrointestinal más común afecta del 10% al 15% de la población mundial.
Yuan Yuan, MD, PhD, a breast medical oncologist and physician scientist who specializes in triple-negative breast cancer and breast cancer immunotherapy, has joined Cedars-Sinai Cancer as director of Breast Oncology. Yuan will treat patients at Cedars-Sinai and at Huntington Cancer Center, an affiliate of Cedars-Sinai Cancer.
Asher Kimchi, MD, clinical chief of Cardiology, vice-clinical chief of the Department of Medicine, and founder and co-medical director of the Preventive and Consultative Heart Center of Excellence at Smidt Heart Institute, passed away Friday, Oct. 7. He was 76.
Antonia “Toni” Perez is one in a million. She’s one of 1 million patients in the U.S. who have received an organ transplant, a milestone the nation celebrated last month.
The Convergent Science Virtual Cancer Center (CSVCC), a program designed to train the next generation of cancer researchers, is holding its first in-person workshop for its first class of scholars. The program, led by Cedars-Sinai Cancer and the University of Southern California, is funded by an inaugural grant from the Department of Defense.
The environment could be playing a critical role in the expression of polycystic ovary syndrome (PCOS) in women living in Alabama, as compared to women in California, according to a new study published in the Journal of Clinical Endocrinology & Metabolism.
Cedars-Sinai Orthopaedic Trauma experts will present their latest advances in treatments and research at the annual meeting of the Orthopaedic Trauma Association (OTA) in Florida Oct. 12-15.
Cedars-Sinai Cancer is welcoming nine oncology specialists to its affiliate, Huntington Cancer Center. The cancer specialists will be based at Huntington’s Pasadena campus, making it easier for San Gabriel Valley residents to access Cedars-Sinai Cancer clinical trials and innovative treatment options.
Two new discoveries led by Cedars-Sinai Cancer investigators help improve the understanding of what drives the development of ovarian cancer and why some women’s tumors do not respond to therapy.
Cedars-Sinai is celebrating Hispanic and Latinx Heritage Month with a specially curated gallery showcasing the work of Hispanic and Latinx artists.
Pioneering heart care is a tradition at Cedars-Sinai. It’s a tradition that took root in 1924, when Cedars-Sinai became home to the first electrocardiogram machine in Los Angeles.
Ser pionero en el cuidado del corazón es una tradición en Cedars-Sinai. Es una tradición que se arraigó en 1924, cuando Cedars-Sinai se convirtió en el hogar de la primera máquina de electrocardiograma en Los Ángeles.
Here is a summary of the September research discoveries and faculty news from Cedars-Sinai.
Cedars-Sinai Guerin Children’s pediatric specialists will share their expertise and recent research findings at the American Academy of Pediatrics Annual Meeting, taking place Oct. 7-11 in Anaheim, California.
A new study led by Cedars-Sinai investigators found using breath tests to identify gut gas profiles can potentially help lead to more personalized therapies for people diagnosed with irritable bowel syndrome (IBS). The most common gastrointestinal disorder affects 10% to15% of the world’s population.
As Breast Cancer Awareness Month begins, Cedars-Sinai Cancer experts are available to discuss new treatments for breast cancer patients and the innovative ways Cedars-Sinai Cancer is making those treatments accessible to all.
Amid the loosening of COVID-19 precautions and a sharp increase in flu cases in the Southern Hemisphere, Cedars-Sinai experts are warning the public to prepare for a bad flu season this year.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
